AlphaYou
Overview
Key stats
Fundamentals Sep 10- Open
- $34.76
- 52-wk high
- $50.88
- High
- $35.09
- 52-wk low
- $32.48
- Low
- $34.01
- Prev close
- $34.69
- Mkt cap
- $45.81B
- P/E
- 42.6x
- Volume
- 5.28M
- Fwd P/E
- 21.1x
- P/S
- 1.5x
- P/B
- 2.6x
- Profit margin
- +2.3%
- Op margin
- +0.8%
- ROE
- +4.9%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Activist stakes, short interest & more
Earnings
Earnings came in 56.7% above what analysts expected.
Earnings per share
$0.30 expected
Revenue
$7.51B expected
GAAP EPS was $0.07 and adjusted EPS was $0.50. The analyst basis could not be confirmed, so no beat or miss is shown.
What the street expects next
EPS expected
$0.28 to $0.47
Revenue expected
21 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Jun 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $6.89B | $7.79B | $7.35B | $7.68B |
| Cost of what it sold | $5.16B | $5.87B | $5.69B | $5.47B |
| Gross profit | $1.73B | $1.91B | $1.67B | $2.21B |
| What it spent | ||||
| Sales and admin | — | $1.26B | $1.23B | $1.29B |
| Other operating costs | $1.10B | $224.0M | $15.0M | $525.0M |
| Total operating expenses | $1.10B | $1.49B | $1.24B | $1.82B |
| What was left | ||||
| Operating profit | $629.0M | $425.0M | $422.0M | $395.0M |
| Interest on debt | $233.0M | $166.0M | $165.0M | $168.0M |
| Profit before tax | $359.0M | $206.0M | $291.0M | $235.0M |
| Tax | $26.0M | $26.0M | $52.0M | $96.0M |
| Net profit | $333.0M | $180.0M | $129.0M | $60.0M |
| EBITDA | $842.0M | $382.0M | $681.0M | $659.0M |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
15 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is mixed
Tone of tracked coverage
Kaplan Fox Announces an Investigation of Medline Inc. (NASDAQ: MDLN) on Behalf of Investors
BearishSep 1Pelham Capital Ltd. Takes Position in Medline $MDLN
Leans bullishSep 1Medline stock reiterated at Buy by BTIG after Illinois facility tour
NeutralAug 27
Macro
32 macro signals shaping MDLN right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results